News Extra [these Stories Appear Only On The Web] Regulatory authorities review use of galantamine in mild cognitive impairment BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7486.276-b (Published 03 February 2005) Cite this as: BMJ 2005;330:276 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Individual care plans reduce falls and broken hips in New Zealand hospitals BMJ December 05, 2016, 355 i6490; DOI: https://doi.org/10.1136/bmj.i6490 One in three with mild cognitive impairment has depression, review finds BMJ November 28, 2016, 355 i6387; DOI: https://doi.org/10.1136/bmj.i6387 Clinical commissioning groups will be rated on sepsis care BMJ November 25, 2016, 355 i6361; DOI: https://doi.org/10.1136/bmj.i6361 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362 GPs award potential £700m contract to Virgin Care BMJ November 14, 2016, 355 i6130; DOI: https://doi.org/10.1136/bmj.i6130
